Yahoo Web Search

  1. Yahoo Finance Results

  2. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK. Over the last one-month, outflows of investor capital in ETFs holding MRK totaled ...

  3. Merck and Co., Inc. MRK gained priority review for yet another supplemental biologics license application (sBLA) for its PD-1 inhibitor, Keytruda. With the latest application ...

    62.51N/A (N/A%)

    at Fri, Jul 20, 2018, 14:59PM EST - U.S. Markets closed

    After Hours 62.52 +0.01 (+0.02%)

    Nasdaq Real Time Price

    • Open 62.06
    • High 62.54
    • Low 62.01
    • Prev. Close 62.51
    • 52 Wk. High 66.41
    • 52 Wk. Low 52.83
    • P/E 108.52
    • Mkt. Cap 168.17B
  4. Trump Attacks Pfizer Over Drug Prices in Latest Dig at Industry

    Bloomberg via Yahoo FinanceJul 09 17:16 PM

    President Donald Trump said Pfizer Inc. should be “ashamed” for raising the prices of its pharmaceutical products, rattling shares of the U.S. drug giant on Monday. “Pfizer & others should ...

  5. Markets were closed on Wednesday for the Fourth of July holiday. The index advanced on Thursday, boosted by tech stocks which posted their best performance in more than a month. Last Week’s ...

  6. Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion

    Zacks via Yahoo FinanceJul 02 12:55 PM

    Gilead Sciences, Inc. GILD announced that European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use ("CHMP") has issued a positive opinion on the company’s Marketing ...

  7. The biggest news this week was Novartis’ NVS announcement of its plans to spin off its eye care division, Alcon, into a new public company. The Committee for Medicinal Products for Human Use ...

  8. Biogen's Alzheimer Disease Candidate Succeeds in Phase II

    Zacks via Yahoo FinanceJul 06 13:35 PM

    Biogen Inc.’s BIIB shares were up around 7% in after-market trading on Thursday on positive top-line data from a mid-stage study evaluating its pipeline candidate...’s disease (AD). Biogen ...

  9. The Board of Trustees supports the Foundation's educational and research mission to improve health outcomes by developing managed care pharmacy leaders. The 2018-19 Board began its term at the ...

  10. Bristol-Myers Squibb Company BMY announced that the European Commission (EC) has approved the label expansion of oncology drug Sprycel. Consequently, the drug is now approved for the treatment ...

  11. 7 Small-Cap Stocks to Consider for the Second Half of 2018

    InvestorPlace via Yahoo FinanceJul 09 15:01 PM

    Small-cap stocks continue to put some distance between themselves and their large-cap brethren. Though the Dow Jones Industrial Average and the S&P 500 ended Monday’s trading in the red on lingering ...

  1. Ad
    related to Merck & Co., Inc